Akeso Biopharma logo

Akeso Biopharma

First in class and best in class therapeutic antibodies for patients worldwide. #9926.HK

105 employees · est. 2012 · China

VS
嘉和生物药业有限公司 logo

嘉和生物药业有限公司

Genor Biopharma (6998.HK) is an innovative company with a pipeline of therapies covering the world's top oncology areas

27 employees · est. 2007 · Shanghai, China

嘉和生物药业有限公司 is the older company (2012 vs 2007); Akeso Biopharma is the larger of the two.

Side-by-Side Comparison

Akeso Biopharma 嘉和生物药业有限公司
Founded
2012 2007 older
Headquarters
China Shanghai, China
Employees
105 larger 27
Industry
Biopharma, Biotechnology, Health Care Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Series D Series B
Total Funding
$608.71M $436.68M
Funding Rounds
4 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Biopharma, Oncology, Therapeutic Antibodies, Innovation-driven, Bioprocess Development, CMC, GMP Manufacturing, Clinical Development, PD-1 Inhibitor, Biologics, Drug Development, NDA Application, Science-driven, Global Reach, Patient-focused
Website
akesobio.com genorbio.com
Akeso Biopharma logo

About Akeso Biopharma

Akeso Biopharma, established in 2012, has positioned itself as a leading global biopharmaceutical organization with a focus on cancer, autoimmune diseases, inflammation, and cardiovascular conditions. The company has developed an extensive bio-pharmaceutical research, development, and industrializat...

嘉和生物药业有限公司 logo

About 嘉和生物药业有限公司

Genor BioPharma Co., Ltd., established in 2007, is an innovative biopharma company focusing on top oncology areas. With its headquarters in China, the company has garnered significant attention, having received a notable $160.00M Series B investment on 01 June 2020 from Temasek Holdings, Cavenham PE...

We will tell you when either one moves

BounceWatch watches Akeso Biopharma and 嘉和生物药业有限公司 for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Akeso Biopharma and 嘉和生物药业有限公司 — by email.

Frequently Asked Questions

Akeso Biopharma — First in class and best in class therapeutic antibodies for patients worldwide. #9926.HK. 嘉和生物药业有限公司 — Genor Biopharma (6998.HK) is an innovative company with a pipeline of therapies covering the world's top oncology areas. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Akeso Biopharma has raised $608.71M while 嘉和生物药业有限公司 has raised $436.68M.
Akeso Biopharma and 嘉和生物药业有限公司 operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Akeso Biopharma with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Akeso Biopharma on 12 Sep 2024, and 嘉和生物药业有限公司 on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes